Trademark Overview
On Wednesday, January 12, 2022, a trademark application was filed for SAY YES! COVID TEST with the United States Patent and Trademark Office. The USPTO has given the SAY YES! COVID TEST trademark a serial number of 97215429. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, February 15, 2023. This trademark is owned by U.S. Department of Health and Human Services. The SAY YES! COVID TEST trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Promoting public awareness of the importance and availability of diagnostic tests and testing services for COVID-19 and severe acute respiratory syndrome (SARS) variants to prevent and control the spread of COVID-19 and severe acute respiratory syndrome (SARS)
Providing healthcare information; providing personalized healthcare and medical information about COVID-19 and severe acute respiratory syndrome (SARS) testing and vaccines; providing reminders, safety alerts and helplines for COVID-19 and severe acute respiratory syndrome (SARS) testing and vaccines; providing healthcare information, via a global internet website, featuring information, alerts, helplines, availability, enrollment in and registration for distribution of COVID-19 testing and vaccines and studies for the same; public health medical services; medical services in the field of diagnostic testing for COVID-19 and severe acute respiratory syndrome (SARS); administration, distribution of COVID-19 and severe acute respiratory syndrome (SARS) diagnostic tests and testing services and digital assistant services in the field of COVID-19 and severe acute respiratory syndrome (SARS) testing and vaccines
Evaluating, analyzing and distributing screening or diagnostic tests and/or devices for detection of viruses; evaluating, analyzing and distributing screening or diagnostic tests and/or devices for detection of COVID-19 and severe acute respiratory syndrome (SARS) variants; providing a website featuring medical, biomedical and scientific research information and opportunities for study participation; providing temporary use of on-line, non-downloadable software for participant enrollment in, information on availability and documentation of clinical studies for screening and diagnostic tests and/or devices for COVID-19 and severe acute respiratory syndrome (SARS) variants; digital assistant services in the field of COVID-19 and severe acute respiratory syndrome (SARS) testing and vaccines
